As of Nov 25
| -0.45 / -0.52%|
The 28 analysts offering 12-month price forecasts for Novartis have a median target of 107.16, with a high estimate of 131.95 and a low estimate of 86.56. The median estimate represents a +24.67% increase from the last price of 85.95.
The current consensus among 31 polled investment analysts is to Buy stock in Novartis. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.